Literature DB >> 2453704

A study of dose-response relationships of allopurinol in the presence of low or high purine turnover.

W Löffler1, W Gröbner.   

Abstract

Effects of allopurinol (125-500 mg/m2 body surface) were studied in normal subjects during periods of 18 days both during a purine-free, isoenergetic liquid formula diet and additional intake of ribonucleic acid, 4 g/day. Plasma uric acid and renal excretion of uric acid, oxypurines (hypoxanthine plus xanthine) and orotic acid were measured and total purine excretion calculated. Effects of allopurinol were evaluated by comparison of the results obtained in the steady state during diet alone (average of days 7-10) with those during allopurinol administration (days 16-18). During the purine-free diet, plasma uric acid was lowered more than urinary uric acid by allopurinol on doses of 250-500 mg/m2 (44%-54% of control values on 500 mg/m2), demonstrating an increase in renal clearance. At the same dose, the uric acid lowering effect of allopurinol was more pronounced with than without purine loads (plasma 41%, urine 32% of control on 500 mg/m2 during purine intake), while renal uric acid clearance was decreased. The more pronounced reduction of uric acid excretion during purine administration was balanced to the greater part by a more pronounced increase in oxypurine excretion. Total purine excretion was reduced by about 20% during the purine-free diet irrespective of dose. The size of this purine deficit was doubled, but was also independent of dose during addition of purines. Orotic acid excretion increased with dose during allopurinol treatment and was reduced by addition of purines.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453704     DOI: 10.1007/bf01727784

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  27 in total

1.  Metabolism of (6-14-c)allopurinollack of incorporation of allopurinol into nucleic acids.

Authors:  D J Nelson; G B Elion
Journal:  Biochem Pharmacol       Date:  1975-06-15       Impact factor: 5.858

2.  Augmentation of the incorporation of hypoxanthine into nucleic acids by the administration of an inhibitor of xanthine oxidase.

Authors:  R POMALES; S BIEBER; R FRIEDMAN; G H HITCHINGS
Journal:  Biochim Biophys Acta       Date:  1963-05-28

3.  Xanthine accumulation during hypoxanthine oxidation by milk xanthine oxidase.

Authors:  M M Jezewska
Journal:  Eur J Biochem       Date:  1973-07-16

4.  Hereditary orotic aciduria. II. A urinary screening test.

Authors:  L E Rogers; F S Porter
Journal:  Pediatrics       Date:  1968-09       Impact factor: 7.124

5.  An enzymatic basis for variation in response to allopurinol. Hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  W N Kelley; F M Rosenbloom; J Miller; J E Seegmiller
Journal:  N Engl J Med       Date:  1968-02-08       Impact factor: 91.245

6.  Allopurinol: alteration in pyrimidine metabolism in man.

Authors:  W N Kelley; T D Beardmore
Journal:  Science       Date:  1970-07-24       Impact factor: 47.728

7.  Allopurinol in the treatment of gout.

Authors:  R W Rundles; E N Metz; H R Silberman
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

8.  [Xanthine-oxidase deficiency (congenital xanthinuria). Family study].

Authors:  J C Desbois; P Cartier; O Petyst; C Allaneau; A Herrault
Journal:  Ann Pediatr (Paris)       Date:  1977-09

9.  Absorption and metabolism of allopurinol and oxypurinol by rat jejunum in vitro: effects on uric acid transport.

Authors:  M I Shaw; D S Parsons
Journal:  Clin Sci (Lond)       Date:  1984-03       Impact factor: 6.124

10.  Formation of nucleotides of (6-14C)allopurinol and (6-14C)oxipurinol in rat tissues and effects on uridine nucleotide pools.

Authors:  D J Nelson; C J Buggé; H C Krasny; G B Elion
Journal:  Biochem Pharmacol       Date:  1973-08-15       Impact factor: 5.858

View more
  5 in total

1.  [Differential indications for uricosuric drugs and allopurinol].

Authors:  W Gröbner; N Zöllner
Journal:  Klin Wochenschr       Date:  1989-03-01

2.  [Dose response relations of allopurinol].

Authors:  D P Mertz
Journal:  Klin Wochenschr       Date:  1988-08-15

3.  Non-responsiveness to allopurinol in renal hypouricaemia.

Authors:  W Löffler; W Seibke; E Seibke; S Reiter; M Jahn; R Hehlmann; N Zöllner
Journal:  Klin Wochenschr       Date:  1989-01-04

4.  Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. I. Uric acid kinetics.

Authors:  W Löffler; R Landthaler; J X de Vries; I Walter-Sack; A Ittensohn; A Voss; N Zöllner
Journal:  Clin Investig       Date:  1994-12

Review 5.  Dietary nucleotides and gut mucosal defence.

Authors:  G K Grimble
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.